
International Flavors & Fragrances company profile
$81.16+0.97%Close 13 Nov 2026 · Market value $20.08B
About International Flavors & Fragrances
International Flavors & Fragrances creates and manufactures products for food, beverage, health & biosciences, and scent applications, along with adjacent products including natural health ingredients. Its products are sold principally to manufacturers in categories such as dairy, meat, beverages, snacks, baked goods, personal care, soaps and detergents, perfumes, dietary supplements, and animal nutrition. Its operating segments in 2025 were Taste, Food Ingredients, Health & Biosciences, and Scent, with Pharma Solutions included until its divestiture in May 2025. In 2025, U.S. sales represented approximately 28% of total sales of $10.890 billion, and no customer accounted for 10% or more of sales. The company operates approximately 170 manufacturing facilities, creative centers and application laboratories in about 30 countries.
A summary of the business section of the company's latest annual report, filed 27 Feb 2026.
Company facts
| Ticker | IFF · NYSE |
|---|
| Sector | Chemicals |
|---|
| Industry | Specialty Chemicals |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 51253 |
|---|
| Latest annual report | 10-K, filed 27 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Paul J. Fribourg | Director | 2.3M · < 1% | Open-market purchase, 1 Jun 2026 |
|---|
| J. Erik Fyrwald | Chief Executive Officer · Director | 123K · < 1% | Option exercise, 1 May 2026 |
|---|
| Jennifer Johnson | EVP, General Counsel | 31.0K · < 1% | Shares withheld for tax, 4 Mar 2025 |
|---|
| Kevin O’Byrne | Director | 27.2K · < 1% | Option exercise, 1 May 2026 |
|---|
| Yuvraj Arora | President, Taste & CCO | 21.3K · < 1% | Option exercise, 1 May 2026 |
|---|
| Michael DeVeau | EVP, CFO | 19.0K · < 1% | Open-market sale, 6 Aug 2026 |
|---|
| Mark J. Costa | Director | 6.6K · < 1% | Option exercise, 1 May 2025 |
|---|
| Andres Muller | President, Food Ingredients | 3.8K | Option exercise, 1 Apr 2026 |
|---|
| Mehmood Khan | Director | 3.2K · < 1% | Option exercise, 1 May 2026 |
|---|
| Vincent Intrieri | Director | 3.2K · < 1% | Option exercise, 1 May 2025 |
|---|
| Cynthia T. Jamison | Director | 3.2K · < 1% | Option exercise, 1 May 2025 |
|---|
| Virginia C. Drosos | Director | 2.4K · < 1% | Option exercise, 1 May 2026 |
|---|
| Brett Icahn | Director | 1.7K · < 1% | Option exercise, 1 May 2026 |
|---|
| Richard Mulligan | Director | 1.7K · < 1% | Option exercise, 1 May 2026 |
|---|
| Teles de Mendonca Ana Paula | President, Scent | — | Open-market sale, 17 Aug 2026 |
|---|
| Birenkrant Marc | Controller & CAO | — | Open-market sale, 7 Aug 2026 |
|---|
| Finzel Ralf | EVP, Global Operations Officer | — | Option exercise, 4 May 2026 |
|---|
| Borg Deborah | EVP, Chief Ppl&Culture Officer | — | Option exercise, 4 May 2026 |
|---|
| Lourenco Leticia Goncalves | President, Health & Bioscience | — | Shares withheld for tax, 1 Apr 2026 |
|---|
| Landsman Stephen N | EVP, General Counsel | — | Option exercise, 1 Apr 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
IFF in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.